Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Clinical trial NCT06311708 · RECRUITING
Trial details
- NCT number
- NCT06311708
- Sponsor
- Tenaya Therapeutics
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-31
- Primary completion
- 2030-03-29
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.